Non-canonical pathways for neuroprotection against Alzheimer’s Disease

preview_player
Показать описание
The Heckmann laboratory examines LANDO-deficiency-induced neuroinflammation to develop new therapeutic avenues for treating diseases, including Alzheimer’s.
━━━━━━━━━━━━━━━━━━━━
Article
────────────────────────────
━━━━━━━━━━━━━━━━━━━━
Contact Information
────────────────────────────
T: +1 813 396 9066
────────────────────────────
Additional Information
━━━━━━━━━━━━━━━━━━━━

────────────────────────────
Social Media
━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━
Research Features
────────────────────────────
━━━━━━━━━━━━━━━━━━━━
#alzheimer
#dementia
#braindisease
━━━━━━━━━━━━━━━━━━━━
Рекомендации по теме